How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk Score
CholeRiskScore
1 other identifier
observational
1,868
1 country
11
Brief Summary
Acute calculous cholecystitis (ACC) is the most common complication of gallstone disease, and laparoscopic cholecystectomy is the gold standard treatment. Several prospective studies have demonstrated that same-admission, early LC (ELC), for ACC is safe when compared with delayed LC (DLC). However, there is still controversy on the indication of ELC in high risk patients with important comorbidities, in cases of severe inflammation of the gallbladder and in patients with ACC and suspicious of a choledocholithiasis. The advantages of ELC in high risk patients with severe comorbidities have been recently questioned, with Tokyo Guidelines 2018 (TG18) proposing an initial conservative management of this cases, assessing the benefit of ELC according to specified criteria. However, the recent CHOCOLATE trial, demonstrated the advantages of ELC over an initial conservative management. Performing an ELC for ACC can be a straightforward procedure for an on-call general surgeon or a very challenging procedure even for experienced hepatopancreaticobiliary (HPB) laparoscopic surgeon, depending on disease features, surgeons experience, centres volumes and resources available. Deciding whether the ELC should be performed by the on-call team or by HPB surgical team, or whether the operation should be delayed are still matter of debate in daily practice. Several preoperative scores assessing the risk of difficult cholecystectomy have been proposed, but they were mainly focused on elective procedures and on risk of conversion to open cholecystectomy or other intraoperative complications. They did not asses the risk of post-operative complications in a subgroup of patients, for whom, indication to ELC by the on-call general surgeon is still questionable according to the more recent guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedFirst Submitted
Initial submission to the registry
August 11, 2020
CompletedFirst Posted
Study publicly available on registry
August 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedMarch 29, 2021
December 1, 2020
7.6 years
August 11, 2020
March 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Increased post-operative complications
Patients who only developed Clavien-Dindo I-II complications were assigned to group 1 (G1), whereas groups 2 (G2) included patients with post-operative complications ≥ IIIa. Patients with post-operative LOS greater than 10 days and who required readmissions within 30 days from the discharge were also assigned to G2.
For at least 30 postoperative days
Number of Participants with Postoperative hemorrhagia
Postoperative hemorrhagia
For at least 30 postoperative days
Number of Participants with Biliary fistula
Biliary fistula
For at least 30 postoperative days
Number of Participants with Jaundice
Jaundice
For at least 30 postoperative days
Number of Participants with Cardiac insufficiency
Cardiac insufficiency
For at least 30 postoperative days
Number of Participants with Heart infarction
Heart infarction
For at least 30 postoperative days
Number of Participants with Respiratory insufficiency
Respiratory insufficiency
For at least 30 postoperative days
Number of Participants with Pulmonary thromboembolism
Pulmonary thromboembolism
For at least 30 postoperative days
Number of Participants with Kidney failure or dialysis
Kidney failure or dialysis
For at least 30 postoperative days
Study Arms (3)
Early surgery Group 1
The surgery is performed within the first 3 days
Early surgery Group 2
Surgery is performed between the fourth and seventh day
Early surgery Group 3
Surgery is performed more than 7 days from the onset of symptoms
Interventions
Eligibility Criteria
CLP surgery patients between January 2013 and December 2018. The diagnosis of acute cholecystitis will be established according to the Tokio Guidelines: * Local signs (pain in right hypochondrium / Murphy's sign). * Systemic (fever / elevated C-reactive protein / leukocytosis) * Ultrasound findings (gallbladder distension, wall thickening, pericolectic fluid or radiological Murphy's sign, associated with gallstones). In all patients, treatment with antibiotics will be carried out according to each hospital's protocols in terms of type and duration.
You may qualify if:
- Patients aged 18 years or older diagnosed with Acute calculous cholecystitis.
- Consecutive patients undergoing early laparoscopic cholecystectomy between January 2013 and December 2018 during admission for the acute episode.
- Minimum 30-day post-operative follow-up.
- ASA ≤ 3.
You may not qualify if:
- Presence of another concomitant pathology of the bile duct (choledocholithiasis, cholangitis, pancreatitis, biliary peritonitis).
- Aetiology other than cholelithiasis (amythiasis, malignancy).
- Patients with severe sepsis, immunosuppression and pregnancy.
- Additional abdominal surgical procedure.
- ASA 4.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Hospital Universitario German Trias I Pujol
Badalona, Barcelona, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, Madrid, Spain
Hospital de Cabueñes
Gijón, Principality of Asturias, Spain
Hospital Universitario Cruces
Bilbao, Vizcaya, Spain
Hospital Universitario de la Princesa
Madrid, 28006, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Complejo Asistencial Universitario Salamanca
Salamanca, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2020
First Posted
August 13, 2020
Study Start
January 1, 2013
Primary Completion
July 31, 2020
Study Completion
September 30, 2020
Last Updated
March 29, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share